IL21 and cancer: Similarly to TGFβ blockade, IL-21 was able to potently inhibit baseline FOXP3 induction in naïve T cells (Fig. 5a) and FOXP3 induction as a result of the addition of cancer cell supernatants (Fig. 5a, b).